HPA AXIS RELATED GENES and RESPONSE to PSYCHOLOGICAL THERAPIES: GENETICS and EPIGENETICS

Depression and Anxiety

Volumn 32, Issue 12, 2015, Pages 861-870

  Roberts, Susanna ^a   Keers, Robert ^a   Lester, Kathryn J ^a,b   Coleman, Jonathan R I ^a   Breen, Gerome ^a,c   Arendt, Kristian ^d   Blatter Meunier, Judith ^e   Cooper, Peter ^f,g   Creswell, Cathy ^f   Fjermestad, Krister ^h   Havik, Odd E ^h   Herren, Chantal ^e   Hogendoorn, Sanne M ⁱ   Hudson, Jennifer L ^j   Krause, Karen ^k   Lyneham, Heidi J ^j   Morris, Talia ^j   Nauta, Maaike ^l   Rapee, Ronald M ^j   Rey, Yasmin ^m   Schneider, Silvia ^k   Schneider, Sophie C ^j   Silverman, Wendy K ⁿ   Thastum, Mikael ^d   Thirlwall, Kerstin ^f   Waite, Polly ^f   Eley, Thalia C ^a   Wong, Chloe C Y ^a   more..

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF SUSSEX   (United Kingdom)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d AARHUS UNIVERSITY   (Denmark)

^e UNIVERSITY OF BASEL   (Switzerland)

^f UNIVERSITY OF READING   (United Kingdom)

^g STELLENBOSCH UNIVERSITY   (South Africa)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ De Bascule   (Netherlands)

^j MACQUARIE UNIVERSITY   (Australia)

^k RUHR UNIVERSITY BOCHUM   (Germany)

^l UNIVERSITY OF GRONINGEN   (Netherlands)

^m FLORIDA INTERNATIONAL UNIVERSITY   (United States)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

anxiety; biological markers; child adolescent; cognitive behavior therapy; DNA methylation; FKBP5; genetics; glucocorticoid receptor; HPA axis; therapygenetics; treatment

Indexed keywords

FK 506 BINDING PROTEIN; FK506 BINDING PROTEIN 5; GLUCOCORTICOID RECEPTOR; UNCLASSIFIED DRUG; NR3C1 PROTEIN, HUMAN; TACROLIMUS BINDING PROTEIN 5;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; CHILD; COGNITIVE THERAPY; DISEASE SEVERITY; DNA METHYLATION; EPIGENETICS; FEMALE; FKBP5 GENE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GR GENE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT RESPONSE; ALLELE; ANXIETY DISORDERS; CLINICAL TRIAL; GENETIC EPIGENESIS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MULTICENTER STUDY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT OUTCOME;

ADOLESCENT; ALLELES; ANXIETY DISORDERS; CHILD; CHILD, PRESCHOOL; COGNITIVE THERAPY; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; FEMALE; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID; TACROLIMUS BINDING PROTEINS; TREATMENT OUTCOME;

EID: 84949624558     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.22430     Document Type: Article

References (45)

1. Binder EB,. The role of FKBP5, a co-chaperone of the glucocorticoid receptor in the pathogenesis and therapy of affective and anxiety disorders. Psychoneuroendocrinology 2009; 34 (Suppl 1): S186-S195.
2. Holsboer F,. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 2000; 23 (5): 477-501.
3. Pariante CM, Miller AH,. Glucocorticoid receptors in major depression: Relevance to pathophysiology and treatment. Biol Psychiatry 2001; 49 (5): 391-404.
4. Denny WB, Valentine DL, Reynolds PD, et al., Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology 2000; 141 (11): 4107-4113.
5. Wochnik GM, Rüegg J, Abel GA, et al., FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem 2005; 280 (6): 4609-4616.
6. Appel K, Schwahn C, Mahler J, et al., Moderation of Adult Depression by a Polymorphism in the FKBP5 Gene and Childhood Physical Abuse in the General Population. Neuropsychopharmacology 2011; 36 (10): 1982-1991.
7. Binder EB, Bradley RG, Liu W, et al., Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008; 299 (11): 1291-1305.
8. Zimmermann P, Brückl T, Nocon A, et al., Interaction of FKBP5 gene variants and adverse life events in predicting depression onset: results from a 10-year prospective community study. Am J Psychiatry 2011; 168 (10): 1107-1116.
9. Roy A, Gorodetsky E, Yuan Q, et al., Interaction of FKBP5, a stress-related gene, with childhood trauma increases the risk for attempting suicide. Neuropsychopharmacology 2010; 35 (8): 1674-1683.
10. Koenen K, Saxe G, Purcell S, et al., Polymorphisms in FKBP5 are associated with peritraumatic dissociation in medically injured children. Mol Psychiatry 2005; 10 (12): 1058-1059.
11. Klengel T, Mehta D, Anacker C, et al., Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci 2013; 16 (1): 33-41.
12. Weaver IC, Cervoni N, Champagne FA, et al., Epigenetic programming by maternal behavior. Nat Neurosci 2004; 7 (8): 847-854.
13. McGowan PO, Sasaki A, D'Alessio AC, et al., Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009; 12 (3): 342-348.
14. Oberlander TF, Weinberg J, Papsdorf M, et al., Prenatal exposure to maternal depression, neonatal methylation of human glucocorticoid receptor gene (NR3C1) and infant cortisol stress responses. Epigenetics 2008; 3 (2): 97-106.
15. Perroud N, Paoloni-Giacobino A, Prada P, et al., Increased methylation of glucocorticoid receptor gene (NR3C1) in adults with a history of childhood maltreatment: a link with the severity and type of trauma. Transl Psychiatry 2011; 1: e59.
16. Radtke KM, Ruf M, Gunter HM, et al., Transgenerational impact of intimate partner violence on methylation in the promoter of the glucocorticoid receptor. Transl Psychiatry 2011; 1: e21.
17. Tyrka AR, Price LH, Marsit C, et al., Childhood adversity and epigenetic modulation of the leukocyte glucocorticoid receptor: preliminary findings in healthy adults. PLoS One 2012; 7 (1): e30148.
18. van der Knaap LJ, Riese H, Hudziak JJ, et al., Glucocorticoid receptor gene (NR3C1) methylation following stressful events between birth and adolescence. Transl Psychiatry 2014; 4: e381.
19. Yehuda R, Flory JD, Bierer LM, et al., Lower methylation of glucocorticoid receptor gene promoter 1F in peripheral blood of veterans with posttraumatic stress disorder. Biol Psychiatry 2014; 77 (4): 356-364.
20. Belsky J, Bakermans-Kranenburg MJ, van IJzendoorn MH,. For Better and For Worse. Curr Dir Psychol Sci 2007; 16 (6): 300-304.
21. VanZomeren-Dohm AA, Pitula CE, Koss KJ, et al., FKBP5 moderation of depressive symptoms in peer victimized, post-institutionalized children. Psychoneuroendocrinology 2015; 51 (0): 426-430.
22. Kessler RC, Berglund P, Demler O, et al., Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005; 62 (6): 593-602.
23. Bittner A, Egger HL, Erkanli A, et al., What do childhood anxiety disorders predict? J Child Psychol Psychiatry 2007; 48 (12): 1174-1183.
24. James AC, James G, Cowdrey FA, et al., Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 6 2013.
25. Eley TC., The future of therapygenetics: where will studies predicting psychological treatment response from genomic markers lead?. Depress Anxiety 2014; 31 (8): 617-620.
26. Eley TC, Hudson JL, Creswell C, et al., Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry 2012; 17 (3): 236-237.
27. Roberts S, Lester KJ, Hudson JL, et al., Serotonin tranporter methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl Psychiatry 2014; 4: e444.
28. Lester KJ, Roberts S, Keers R, et al., Non-replication of the association between 5HTTLPR and response to psychological therapy for child anxiety disorders. Br J Psychiatry, 2015.
29. Perroud N, Salzmann A, Prada P, et al., Response to psychotherapy in borderline personality disorder and methylation status of the BDNF gene. Transl Psychiatry 2013; 3 (1): e207.
30. Lester K, Hudson J, Tropeano M, et al., Neurotrophic gene polymorphisms and response to psychological therapy. Transl Psychiatry 2012; 2 (5): e108.
31. Lester K, Eley T,. Therapygenetics: using genetic markers to predict response to psychological treatment for mood and anxiety disorders. Biol Mood Anxiety Disord 2013; 3 (1): 4.
32. Wilker S, Pfeiffer A, Kolassa S, et al., The role of FKBP5 genotype in moderating long-term effectiveness of exposure-based psychotherapy for posttraumatic stress disorder. Transl Psychiatry 2014; 4: e403.
33. Yehuda R, Daskalakis NP, Desarnaud F, et al., Epigenetic biomarkers as predictors and correlates of symptom improvement following psychotherapy in combat veterans with PTSD. Frontiers Psychiatry 2013; 4.
34. Schalkwyk LC, Meaburn EL, Smith R, et al., Allelic skewing of DNA methylation is widespread across the genome. Am J Hum Genet 2010; 86 (2): 196-212.
35. Kerkel K, Spadola A, Yuan E, et al., Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet 2008; 40 (7): 904-908.
36. Hudson JL, Keers R, Roberts S, et al., Clinical predictors of response to cognitive-behavioral therapy in pediatric anxiety disorders: the genes for treatment (GxT) study. J Am Acad Child Adolesc Psychiatry 2015.
37. Silverman WK, Albano AM,. Anxiety Disorders Interview Schedule for DSM-IV: Parent Interview Schedule. Oxford University Press; 1996.
38. Unnewehr S, Schneider S, Margraf J,. Diagnostisches Interview bei psychischen Störungen im Kindes-und Jugendalter (Kinder-DIPS). Heidelberg: Springer 1995.
39. Freeman B, Smith N, Curtis C, et al., DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav Genet 2003; 33 (1): 67-72.
40. DNAGenotek. Laboratory protocol for manual purification of DNA from.5mL of sample.
41. Mehta D, Gonik M, Klengel T, et al., Using polymorphisms in FKBP5 to define biologically distinct subtypes of posttraumatic stress disorder: evidence from endocrine and gene expression studies. Arch Gen Psychiatry 2011; 68 (9): 901-910.
42. StataCorp. Stata Statistical Software: Release 11. College Station, TX: StataCorp LP; 2009.
43. Davies M, Volta M, Pidsley R, et al., Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol 2012; 13 (6): 1-14.
44. Lowe R, Gemma C, Beyan H, et al., Buccals are likely to be a more informative surrogate tissue than blood for epigenome-wide association studies. Epigenetics 2013; 8 (4): 445-454.
45. Nyholt DR,. A simple correction for multiple testing for SNPs in linkage disequilibrium with each other. Am J Hum Genet 2004; 74 (4): 765-769.